Global Postoperative Pain Therapeutics Market
Global Postoperative Pain Therapeutics Market

Postoperative Pain Therapeutics Comprehensive Study by Type (Opioids, NSAIDS, Local anesthetics, Tricyclic antidepressants, Antiepileptic drugs, Others), Route of Administration (Oral, Intramuscular, Intravenous, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) Players and Region - Global Market Outlook to 2025

Postoperative Pain Therapeutics Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Nov 2020 Edition 238 Pages 210 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Postoperative Pain Therapeutics?
Postoperative Pain Therapeutics is referred to as to reduce or eliminate pain and discomfort with a minimum of side effects. Postoperative pain is a confluence of somatic, sensory, and psychological responses to surgical injury. Pain is of two types that is acute pain and chronic pain. Both acute and chronic pain can arise from cutaneous, deep somatic, or visceral structures. Increase in the number of surgical procedure is driving the market, while short-term challenges due to reduced operations across different Industries & economic crisis caused by COVID-19 pandemic across the world is also there.

The market study is broken down by Type (Opioids, NSAIDS, Local anesthetics, Tricyclic antidepressants, Antiepileptic drugs and Others) and major geographies with country level break-up.

The vendors in this market are majorly focusing on developing innovative services in order to cater to the market's demands to remain competitive in the global market. According to the recent global industry crisis due to outbreak of COVID-19 is expected to be one of the major challenges for the vendors of this market as the production and markets of different industries have been shut down for an ambiguous period of time. Research Analyst at AMA estimates that Players from United States will contribute to the maximum growth of Global Postoperative Pain Therapeutics market throughout the predicted period.

Mallinckrodt Pharmaceuticals (United Kingdom), Pacira BioSciences (United States), Trevena (United States), Heron Therapeutics (United States), Pfizer (United States), Teva Pharmaceutical Industries Ltd. (Israel), Novartis AG (Switzerland), Camarus (Sweden), Eli Lilly & Company and Bayer AG (Germany) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Postoperative Pain Therapeutics market by Type, Application and Region.

On the basis of geography, the market of Postoperative Pain Therapeutics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Route of Administration, the sub-segment i.e. Oral will boost the Postoperative Pain Therapeutics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Postoperative Pain Therapeutics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.




Market Trend
  • Introduction of Promising Drugs in the Market
  • Changing Healthcare Scenario and Growing Awareness About the Postoperative Pain and Trauma

Market Drivers
  • High Incidences and Severity of Postoperative Pain
  • Increase in the Number of Surgical Procedures

Opportunities
  • High Adoption Rate of Pain Management in Developed as well as Emerging Markets


Challenges
  • Short-term Challenges due to Reduced Operations Across Different Industries & Economic Crisis caused by COVID-19 Pandemic Across the World


Key Target Audience
Providers of Postoperative Pain Therapeutics, End-Users, Potential Investors, Regulatory Bodies, Market Research Firms and Others

About Approach
During this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Opioids
  • NSAIDS
  • Local anesthetics
  • Tricyclic antidepressants
  • Antiepileptic drugs
  • Others
By Route of Administration
  • Oral
  • Intramuscular
  • Intravenous
  • Others

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Incidences and Severity of Postoperative Pain
      • 3.2.2. Increase in the Number of Surgical Procedures
    • 3.3. Market Challenges
      • 3.3.1. Short-term Challenges due to Reduced Operations Across Different Industries & Economic Crisis caused by COVID-19 Pandemic Across the World
    • 3.4. Market Trends
      • 3.4.1. Introduction of Promising Drugs in the Market
      • 3.4.2. Changing Healthcare Scenario and Growing Awareness About the Postoperative Pain and Trauma
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Postoperative Pain Therapeutics, by Type, Route of Administration, Distribution Channel and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Postoperative Pain Therapeutics (Value)
      • 5.2.1. Global Postoperative Pain Therapeutics by: Type (Value)
        • 5.2.1.1. Opioids
        • 5.2.1.2. NSAIDS
        • 5.2.1.3. Local anesthetics
        • 5.2.1.4. Tricyclic antidepressants
        • 5.2.1.5. Antiepileptic drugs
        • 5.2.1.6. Others
      • 5.2.2. Global Postoperative Pain Therapeutics by: Route of Administration (Value)
        • 5.2.2.1. Oral
        • 5.2.2.2. Intramuscular
        • 5.2.2.3. Intravenous
        • 5.2.2.4. Others
      • 5.2.3. Global Postoperative Pain Therapeutics by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Online Pharmacies
        • 5.2.3.4. Others
      • 5.2.4. Global Postoperative Pain Therapeutics Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Postoperative Pain Therapeutics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Mallinckrodt Pharmaceuticals (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pacira BioSciences (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Trevena (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Heron Therapeutics (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novartis AG (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Camarus (Sweden)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eli Lilly & Company
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bayer AG (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Postoperative Pain Therapeutics Sale, by Type, Route of Administration, Distribution Channel and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Postoperative Pain Therapeutics (Value)
      • 7.2.1. Global Postoperative Pain Therapeutics by: Type (Value)
        • 7.2.1.1. Opioids
        • 7.2.1.2. NSAIDS
        • 7.2.1.3. Local anesthetics
        • 7.2.1.4. Tricyclic antidepressants
        • 7.2.1.5. Antiepileptic drugs
        • 7.2.1.6. Others
      • 7.2.2. Global Postoperative Pain Therapeutics by: Route of Administration (Value)
        • 7.2.2.1. Oral
        • 7.2.2.2. Intramuscular
        • 7.2.2.3. Intravenous
        • 7.2.2.4. Others
      • 7.2.3. Global Postoperative Pain Therapeutics by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Online Pharmacies
        • 7.2.3.4. Others
      • 7.2.4. Global Postoperative Pain Therapeutics Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Postoperative Pain Therapeutics: by Type(USD Million)
  • Table 2. Postoperative Pain Therapeutics Opioids , by Region USD Million (2014-2019)
  • Table 3. Postoperative Pain Therapeutics NSAIDS , by Region USD Million (2014-2019)
  • Table 4. Postoperative Pain Therapeutics Local anesthetics , by Region USD Million (2014-2019)
  • Table 5. Postoperative Pain Therapeutics Tricyclic antidepressants , by Region USD Million (2014-2019)
  • Table 6. Postoperative Pain Therapeutics Antiepileptic drugs , by Region USD Million (2014-2019)
  • Table 7. Postoperative Pain Therapeutics Others , by Region USD Million (2014-2019)
  • Table 8. Postoperative Pain Therapeutics: by Route of Administration(USD Million)
  • Table 9. Postoperative Pain Therapeutics Oral , by Region USD Million (2014-2019)
  • Table 10. Postoperative Pain Therapeutics Intramuscular , by Region USD Million (2014-2019)
  • Table 11. Postoperative Pain Therapeutics Intravenous , by Region USD Million (2014-2019)
  • Table 12. Postoperative Pain Therapeutics Others , by Region USD Million (2014-2019)
  • Table 13. Postoperative Pain Therapeutics: by Distribution Channel(USD Million)
  • Table 14. Postoperative Pain Therapeutics Hospital Pharmacies , by Region USD Million (2014-2019)
  • Table 15. Postoperative Pain Therapeutics Retail Pharmacies , by Region USD Million (2014-2019)
  • Table 16. Postoperative Pain Therapeutics Online Pharmacies , by Region USD Million (2014-2019)
  • Table 17. Postoperative Pain Therapeutics Others , by Region USD Million (2014-2019)
  • Table 18. South America Postoperative Pain Therapeutics, by Country USD Million (2014-2019)
  • Table 19. South America Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 20. South America Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 21. South America Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 22. Brazil Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 23. Brazil Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 24. Brazil Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 25. Argentina Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 26. Argentina Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 27. Argentina Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 28. Rest of South America Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 29. Rest of South America Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 30. Rest of South America Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 31. Asia Pacific Postoperative Pain Therapeutics, by Country USD Million (2014-2019)
  • Table 32. Asia Pacific Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 33. Asia Pacific Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 34. Asia Pacific Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 35. China Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 36. China Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 37. China Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 38. Japan Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 39. Japan Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 40. Japan Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 41. India Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 42. India Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 43. India Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 44. South Korea Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 45. South Korea Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 46. South Korea Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 47. Taiwan Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 48. Taiwan Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 49. Taiwan Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 50. Australia Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 51. Australia Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 52. Australia Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 53. Rest of Asia-Pacific Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 54. Rest of Asia-Pacific Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 55. Rest of Asia-Pacific Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 56. Europe Postoperative Pain Therapeutics, by Country USD Million (2014-2019)
  • Table 57. Europe Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 58. Europe Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 59. Europe Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 60. Germany Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 61. Germany Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 62. Germany Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 63. France Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 64. France Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 65. France Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 66. Italy Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 67. Italy Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 68. Italy Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 69. United Kingdom Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 70. United Kingdom Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 71. United Kingdom Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 72. Netherlands Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 73. Netherlands Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 74. Netherlands Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 75. Rest of Europe Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 76. Rest of Europe Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 77. Rest of Europe Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 78. MEA Postoperative Pain Therapeutics, by Country USD Million (2014-2019)
  • Table 79. MEA Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 80. MEA Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 81. MEA Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 82. Middle East Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 83. Middle East Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 84. Middle East Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 85. Africa Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 86. Africa Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 87. Africa Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 88. North America Postoperative Pain Therapeutics, by Country USD Million (2014-2019)
  • Table 89. North America Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 90. North America Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 91. North America Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 92. United States Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 93. United States Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 94. United States Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 95. Canada Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 96. Canada Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 97. Canada Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 98. Mexico Postoperative Pain Therapeutics, by Type USD Million (2014-2019)
  • Table 99. Mexico Postoperative Pain Therapeutics, by Route of Administration USD Million (2014-2019)
  • Table 100. Mexico Postoperative Pain Therapeutics, by Distribution Channel USD Million (2014-2019)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Postoperative Pain Therapeutics: by Type(USD Million)
  • Table 112. Postoperative Pain Therapeutics Opioids , by Region USD Million (2020-2025)
  • Table 113. Postoperative Pain Therapeutics NSAIDS , by Region USD Million (2020-2025)
  • Table 114. Postoperative Pain Therapeutics Local anesthetics , by Region USD Million (2020-2025)
  • Table 115. Postoperative Pain Therapeutics Tricyclic antidepressants , by Region USD Million (2020-2025)
  • Table 116. Postoperative Pain Therapeutics Antiepileptic drugs , by Region USD Million (2020-2025)
  • Table 117. Postoperative Pain Therapeutics Others , by Region USD Million (2020-2025)
  • Table 118. Postoperative Pain Therapeutics: by Route of Administration(USD Million)
  • Table 119. Postoperative Pain Therapeutics Oral , by Region USD Million (2020-2025)
  • Table 120. Postoperative Pain Therapeutics Intramuscular , by Region USD Million (2020-2025)
  • Table 121. Postoperative Pain Therapeutics Intravenous , by Region USD Million (2020-2025)
  • Table 122. Postoperative Pain Therapeutics Others , by Region USD Million (2020-2025)
  • Table 123. Postoperative Pain Therapeutics: by Distribution Channel(USD Million)
  • Table 124. Postoperative Pain Therapeutics Hospital Pharmacies , by Region USD Million (2020-2025)
  • Table 125. Postoperative Pain Therapeutics Retail Pharmacies , by Region USD Million (2020-2025)
  • Table 126. Postoperative Pain Therapeutics Online Pharmacies , by Region USD Million (2020-2025)
  • Table 127. Postoperative Pain Therapeutics Others , by Region USD Million (2020-2025)
  • Table 128. South America Postoperative Pain Therapeutics, by Country USD Million (2020-2025)
  • Table 129. South America Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 130. South America Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 131. South America Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 132. Brazil Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 133. Brazil Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 134. Brazil Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 135. Argentina Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 136. Argentina Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 137. Argentina Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 138. Rest of South America Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 139. Rest of South America Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 140. Rest of South America Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 141. Asia Pacific Postoperative Pain Therapeutics, by Country USD Million (2020-2025)
  • Table 142. Asia Pacific Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 143. Asia Pacific Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 144. Asia Pacific Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 145. China Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 146. China Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 147. China Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 148. Japan Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 149. Japan Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 150. Japan Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 151. India Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 152. India Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 153. India Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 154. South Korea Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 155. South Korea Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 156. South Korea Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 157. Taiwan Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 158. Taiwan Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 159. Taiwan Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 160. Australia Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 161. Australia Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 162. Australia Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 163. Rest of Asia-Pacific Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 164. Rest of Asia-Pacific Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 165. Rest of Asia-Pacific Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 166. Europe Postoperative Pain Therapeutics, by Country USD Million (2020-2025)
  • Table 167. Europe Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 168. Europe Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 169. Europe Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 170. Germany Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 171. Germany Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 172. Germany Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 173. France Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 174. France Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 175. France Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 176. Italy Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 177. Italy Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 178. Italy Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 179. United Kingdom Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 180. United Kingdom Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 181. United Kingdom Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 182. Netherlands Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 183. Netherlands Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 184. Netherlands Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 185. Rest of Europe Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 186. Rest of Europe Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 187. Rest of Europe Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 188. MEA Postoperative Pain Therapeutics, by Country USD Million (2020-2025)
  • Table 189. MEA Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 190. MEA Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 191. MEA Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 192. Middle East Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 193. Middle East Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 194. Middle East Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 195. Africa Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 196. Africa Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 197. Africa Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 198. North America Postoperative Pain Therapeutics, by Country USD Million (2020-2025)
  • Table 199. North America Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 200. North America Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 201. North America Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 202. United States Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 203. United States Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 204. United States Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 205. Canada Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 206. Canada Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 207. Canada Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 208. Mexico Postoperative Pain Therapeutics, by Type USD Million (2020-2025)
  • Table 209. Mexico Postoperative Pain Therapeutics, by Route of Administration USD Million (2020-2025)
  • Table 210. Mexico Postoperative Pain Therapeutics, by Distribution Channel USD Million (2020-2025)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Postoperative Pain Therapeutics: by Type USD Million (2014-2019)
  • Figure 5. Global Postoperative Pain Therapeutics: by Route of Administration USD Million (2014-2019)
  • Figure 6. Global Postoperative Pain Therapeutics: by Distribution Channel USD Million (2014-2019)
  • Figure 7. South America Postoperative Pain Therapeutics Share (%), by Country
  • Figure 8. Asia Pacific Postoperative Pain Therapeutics Share (%), by Country
  • Figure 9. Europe Postoperative Pain Therapeutics Share (%), by Country
  • Figure 10. MEA Postoperative Pain Therapeutics Share (%), by Country
  • Figure 11. North America Postoperative Pain Therapeutics Share (%), by Country
  • Figure 12. Global Postoperative Pain Therapeutics share by Players 2019 (%)
  • Figure 13. Global Postoperative Pain Therapeutics share by Players (Top 3) 2019(%)
  • Figure 14. Global Postoperative Pain Therapeutics share by Players (Top 5) 2019(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Mallinckrodt Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 17. Mallinckrodt Pharmaceuticals (United Kingdom) Revenue: by Geography 2019
  • Figure 18. Pacira BioSciences (United States) Revenue, Net Income and Gross profit
  • Figure 19. Pacira BioSciences (United States) Revenue: by Geography 2019
  • Figure 20. Trevena (United States) Revenue, Net Income and Gross profit
  • Figure 21. Trevena (United States) Revenue: by Geography 2019
  • Figure 22. Heron Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 23. Heron Therapeutics (United States) Revenue: by Geography 2019
  • Figure 24. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 25. Pfizer (United States) Revenue: by Geography 2019
  • Figure 26. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 27. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2019
  • Figure 28. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. Novartis AG (Switzerland) Revenue: by Geography 2019
  • Figure 30. Camarus (Sweden) Revenue, Net Income and Gross profit
  • Figure 31. Camarus (Sweden) Revenue: by Geography 2019
  • Figure 32. Eli Lilly & Company Revenue, Net Income and Gross profit
  • Figure 33. Eli Lilly & Company Revenue: by Geography 2019
  • Figure 34. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Bayer AG (Germany) Revenue: by Geography 2019
  • Figure 36. Global Postoperative Pain Therapeutics: by Type USD Million (2020-2025)
  • Figure 37. Global Postoperative Pain Therapeutics: by Route of Administration USD Million (2020-2025)
  • Figure 38. Global Postoperative Pain Therapeutics: by Distribution Channel USD Million (2020-2025)
  • Figure 39. South America Postoperative Pain Therapeutics Share (%), by Country
  • Figure 40. Asia Pacific Postoperative Pain Therapeutics Share (%), by Country
  • Figure 41. Europe Postoperative Pain Therapeutics Share (%), by Country
  • Figure 42. MEA Postoperative Pain Therapeutics Share (%), by Country
  • Figure 43. North America Postoperative Pain Therapeutics Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Mallinckrodt Pharmaceuticals (United Kingdom)
  • Pacira BioSciences (United States)
  • Trevena (United States)
  • Heron Therapeutics (United States)
  • Pfizer (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Novartis AG (Switzerland)
  • Camarus (Sweden)
  • Eli Lilly & Company
  • Bayer AG (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation